E-DRUG: Special 301: Resist the Watch List
-------------------------------------------------------
[The US Government has bullied governments of less developed countries to stop them using the legal flexibilities allowed under the TRIPS agreement. BS]
http://www.citizen.org/documents/public-citizen-special-301-review-comments-february-2017.pdf
Our comments call for eliminating Special 301, the U.S. government's annual intellectual property watch list, which is a lobbyist-driven exercise to bully other countries at the expense of people's health.
We establish minimum principles to which we think any 301-type process must nevertheless adhere, including omitting any reference to a country's TRIPS-compliant policies that advance access to medicines.
And we analyze laws & public interest policy developments in countries that USTR has previously watch-listed, including: Argentina, Brazil, Canada, Chile, Colombia, Ecuador, India, Indonesia, Peru, Turkey and Vietnam.
Peter Maybarduk
Public Citizen Organisation
USA
Peter Maybarduk <pmaybarduk@citizen.org>